loader
Please Wait
Applying Filters...

SPI Pharma Corp Ad SPI Pharma Corp Ad

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of Health Canada Patents covering 4-[bis(1,1,2,2,2-pentadeuterioethyl)amino]but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate.

    Client Email Product
    Menu

    4-[bis(1,1,2,2,2-pentadeuterioethyl)amino]but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    REF. STANDARDS & IMPURITIES

    DIGITAL CONTENT

    PharmaCompass

    Temad- We think of world-class quality.

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Gowling WLG (Canada) LLP (1)

    filter

    01 2406064 (1)

    filter

    01 Oxybutynin (1)

    filter

    01 Transdermal Patch (1)

    filter

    01 2021-04-24 (1)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Gowling WLG (Canada) LLP

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Oxybutynin

    PDF Supplier PDF
    URL Supplier Web Content
    2406064
    36 mg
    Transdermal Patch
    Human
    2021-04-24
    2011-03-15
    2001-04-24
    OXYTROL
    Transdermal
    Abbvie CB

    Pharmaconex 2024

    Not Confirmed

    envelop Contact Supplier
    Post Enquiry
    POST ENQUIRY